Amarin Corp Plcuk (AMRN) EPS (Basic) Growth (5y) (2015 - 2026)
Amarin Corp Plcuk (AMRN) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.85 Bn | 633.09 Bn | 17.26 Bn |
| 2 | AbbVie | 471.53 Bn | 464.96 Bn | 12.70 Bn |
| 3 | Merck | 380.02 Bn | 372.88 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.58 Bn | 295.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.47 Bn | 253.57 Bn | 12.86 Bn |
| 6 | Amgen | 237.24 Bn | 223.25 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.09 Bn | 179.91 Bn | 6.22 Bn |
| 8 | Pfizer | 161.82 Bn | 150.12 Bn | 10.94 Bn |
| 9 | Gsk | 105.93 Bn | 101.77 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.87 Bn | 5.56 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -83.19% |
| Mar 31, 2026 | -161.28% |
| Dec 31, 2025 | -45.73% |
| Sep 30, 2025 | -84.51% |
| Jun 30, 2025 | -127.87% |
| Mar 31, 2025 | -67.90% |
| Dec 31, 2024 | -50.55% |
| Sep 30, 2024 | -44.03% |
| Jun 30, 2024 | 21.73% |
| Mar 31, 2024 | -45.54% |
| Dec 31, 2023 | 34.00% |
| Sep 30, 2023 | 10.60% |
| Jun 30, 2023 | 18.05% |
| Mar 31, 2023 | 13.66% |
| Dec 31, 2022 | 15.16% |
| Sep 30, 2022 | 20.49% |
| Jun 30, 2022 | -28.39% |
| Mar 31, 2022 | -0.47% |
| Dec 31, 2021 | 17.99% |
| Sep 30, 2021 | 15.15% |